Published in Oncogene on August 06, 2012
IGF binding protein 2 is a cell-autonomous factor supporting survival and migration of acute leukemia cells. J Hematol Oncol (2013) 0.85
Wnt signaling in cancer stem cells and colon cancer metastasis. F1000Res (2016) 0.84
IGFBP-2 - taking the lead in growth, metabolism and cancer. J Cell Commun Signal (2015) 0.84
Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis. Oncotarget (2015) 0.81
Linking patient outcome to high throughput protein expression data identifies novel regulators of colorectal adenocarcinoma aggressiveness. F1000Res (2015) 0.80
Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression. Oncogene (2015) 0.80
Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease. Clin Transl Gastroenterol (2016) 0.78
12-O-Tetradecanoylphorbol-13-Acetate Induces Up-Regulated Transcription of Variant 1 but Not Variant 2 of VIL2 in Esophageal Squamous Cell Carcinoma Cells via ERK1/2/AP-1/Sp1 Signaling. PLoS One (2015) 0.77
The Wnt Target Gene L1 in Colon Cancer Invasion and Metastasis. Cancers (Basel) (2016) 0.76
A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10. Oncogene (2016) 0.75
Silencing IGFBP-2 decreases pancreatic cancer metastasis and enhances chemotherapeutic sensitivity. Oncotarget (2017) 0.75
The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A (1999) 10.75
The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene (2007) 4.90
The outer boundary of the cytoskeleton: a lamina derived from plasma membrane proteins. Cell (1979) 3.66
Mechanisms of regulating tubulin synthesis in cultured mammalian cells. Cell (1979) 3.19
Protein synthesis requires cell-surface contact while nuclear events respond to cell shape in anchorage-dependent fibroblasts. Cell (1980) 2.80
Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol Cell Biol (1990) 2.73
Inhibition of beta-catenin-mediated transactivation by cadherin derivatives. Proc Natl Acad Sci U S A (1998) 2.55
Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin. J Cell Biol (1998) 2.38
Plakoglobin and beta-catenin: protein interactions, regulation and biological roles. J Cell Sci (2000) 2.32
The control of mRNA production, translation and turnover in suspended and reattached anchorage-dependent fibroblasts. Cell (1978) 2.19
Differential mechanisms of LEF/TCF family-dependent transcriptional activation by beta-catenin and plakoglobin. Mol Cell Biol (2000) 1.93
Modulation of bacterial entry into epithelial cells by association between vinculin and the Shigella IpaA invasin. EMBO J (1997) 1.90
Suppression of tumorigenicity in transformed cells after transfection with vinculin cDNA. J Cell Biol (1992) 1.89
Regulation of actin mRNA levels and translation responds to changes in cell configuration. Mol Cell Biol (1983) 1.86
Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin. Cancer Res (2001) 1.83
Targeted disruption of vinculin genes in F9 and embryonic stem cells changes cell morphology, adhesion, and locomotion. Proc Natl Acad Sci U S A (1995) 1.82
The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem (2000) 1.77
Gastrointestinal stem cells in development and cancer. J Pathol (2009) 1.73
The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol (2001) 1.73
Suppression of tumorigenicity in simian virus 40-transformed 3T3 cells transfected with alpha-actinin cDNA. Proc Natl Acad Sci U S A (1993) 1.69
Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J (2001) 1.69
Cyclosporin A suppresses the expression of the interleukin 2 gene by inhibiting the binding of lymphocyte-specific factors to the IL-2 enhancer. EMBO J (1990) 1.66
Excess beta-catenin promotes accumulation of transcriptionally active p53. EMBO J (1999) 1.63
Suppression of vinculin expression by antisense transfection confers changes in cell morphology, motility, and anchorage-dependent growth of 3T3 cells. J Cell Biol (1993) 1.61
Down-regulation of beta-catenin by activated p53. Mol Cell Biol (2001) 1.60
Regulation of beta-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system. J Cell Biol (1997) 1.59
Overexpression of vinculin suppresses cell motility in BALB/c 3T3 cells. Cell Motil Cytoskeleton (1992) 1.57
Differential control of cytokeratins and vimentin synthesis by cell-cell contact and cell spreading in cultured epithelial cells. J Cell Biol (1984) 1.57
Patterning and nuclear beta-catenin expression in the colonic adenoma-carcinoma sequence. Analogies with embryonic gastrulation. Am J Pathol (2000) 1.56
Caveolin-1 expression inhibits Wnt/beta-catenin/Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains. J Biol Chem (2000) 1.51
Focal adhesion formation by F9 embryonal carcinoma cells after vinculin gene disruption. J Cell Sci (1995) 1.50
Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene (1990) 1.45
Suppression of tumorigenicity by plakoglobin: an augmenting effect of N-cadherin. J Cell Biol (1996) 1.36
The clinical spectrum of band erosion following laparoscopic adjustable silicone gastric banding for morbid obesity. Surg Endosc (2003) 1.35
Heterogeneity among Whipple's-disease-associated bacteria. Lancet (1994) 1.28
The cyclin D1 gene is transcriptionally repressed by caveolin-1. J Biol Chem (2000) 1.28
Modulation of alpha-actinin levels affects cell motility and confers tumorigenicity on 3T3 cells. J Cell Sci (1994) 1.26
Differential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome system. Oncogene (2000) 1.25
Regulation of fibronectin, integrin and cytoskeleton expression in differentiating adipocytes: inhibition by extracellular matrix and polylysine. Differentiation (1989) 1.23
The cytoskeleton in cancer cells. Biochim Biophys Acta (1985) 1.22
The state of actin assembly regulates actin and vinculin expression by a feedback loop. J Cell Sci (1995) 1.22
The metabolism of SV40 RNA is associated with the cytoskeletal framework. Virology (1981) 1.22
The intestine-specific homeobox gene Cdx2 decreases mobility and antagonizes dissemination of colon cancer cells. Oncogene (2007) 1.21
Predictive value of nuclear beta-catenin expression for the occurrence of distant metastases in rectal cancer. Dis Colon Rectum (1998) 1.20
Cell contact- and shape-dependent regulation of vinculin synthesis in cultured fibroblasts. Nature (1986) 1.18
Cadherin sequences that inhibit beta-catenin signaling: a study in yeast and mammalian cells. Mol Biol Cell (2001) 1.13
Herpes simplex virus and protein transport are associated with the cytoskeletal framework and the nuclear matrix in infected BSC-1 cells. Virology (1983) 1.13
Multinucleation and inhibition of cytokinesis in suspended cells: reversal upon reattachment to a substrate. Cell (1981) 1.10
Octamer factors exert a dual effect on the IL-2 and IL-4 promoters. J Immunol (1994) 1.09
Cell configuration-related control of vimentin biosynthesis and phosphorylation in cultured mammalian cells. J Cell Biol (1983) 1.09
Autoregulation of actin synthesis responds to monomeric actin levels. J Cell Biochem (1997) 1.08
Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes. J Immunol (1999) 1.08
SV40 virions and viral RNA metabolism are associated with cellular substructures. EMBO J (1982) 1.07
In vitro regulation of granulosa cell differentiation. Involvement of cytoskeletal protein expression. J Biol Chem (1987) 1.07
Frizzled-7 dictates three-dimensional organization of colorectal cancer cell carcinoids. Oncogene (2006) 1.05
Recruitment of beta-catenin to cadherin-mediated intercellular adhesions is involved in myogenic induction. J Cell Sci (2001) 1.03
Regulation of cytoskeletal proteins involved in cell contact formation during differentiation of granulosa cells on extracellular matrix. Proc Natl Acad Sci U S A (1986) 1.03
Regulation of adherens junction protein expression in growth-activated 3T3 cells and in regenerating liver. Exp Cell Res (1992) 1.03
Cancer cell invasion and EMT marker expression: a three-dimensional study of the human cancer-host interface. J Pathol (2014) 1.01
Cell density and cell shape-related regulation of vimentin and cytokeratin synthesis. Inhibition of vimentin synthesis and appearance of a new 45 kD cytokeratin in dense epithelial cell cultures. Exp Cell Res (1985) 0.99
Epithelial-mesenchymal and mesenchymal-epithelial transitions during cancer progression. Verh Dtsch Ges Pathol (2007) 0.99
Control of late simian virus 40 transcription by the attenuation mechanism and transcriptionally active ternary complexes are associated with the nuclear matrix. J Mol Biol (1984) 0.96
Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy. Anticancer Res (2003) 0.95
Tumor escape mechanisms from immunosurveillance: induction of unresponsiveness in a specific MHC-restricted CD4+ human T cell clone by the autologous MHC class II+ melanoma. Int Immunol (1993) 0.95
Cytoplasmic control of cell adhesion. Cold Spring Harb Symp Quant Biol (1992) 0.94
Tumor promoter-induced disruption of junctional complexes in cultured epithelial cells is followed by the inhibition of cytokeratin and desmoplakin synthesis. Exp Cell Res (1986) 0.93
Negative transcriptional regulation in anergic T cells. Proc Natl Acad Sci U S A (1995) 0.93
7-Deaza-2'-deoxyguanosine allows PCR and sequencing reactions from CpG islands. Mol Pathol (2002) 0.93
Differential expression of intermediate filament proteins in metastatic and nonmetastatic variants of the BSp73 tumor. Cancer Res (1986) 0.93
Reduced expression of plakoglobin correlates with adverse outcome in patients with neuroblastoma. Am J Pathol (2001) 0.92
Autoregulation of actin synthesis requires the 3'-UTR of actin mRNA and protects cells from actin overproduction. J Cell Biochem (1999) 0.92
Modulation of the metastatic capability in B16 melanoma by cell shape. Science (1983) 0.91
The regulation of RNA metabolism in suspended and reattached anchorage-dependent 3T6 fibroblasts. J Cell Physiol (1980) 0.91
Cell shape, the complex cellular networks, and gene expression. Cytoskeletal protein genes as a model system. Cell Muscle Motil (1985) 0.91
Tip60 is a cell-type-specific transcriptional regulator. J Biochem (2001) 0.91
Securin (hPTTG1) expression is regulated by beta-catenin/TCF in human colorectal carcinoma. Br J Cancer (2006) 0.90
Intrasellar malignant lymphoma developing within pituitary adenoma. Acta Neuropathol (1999) 0.90
Virus replication in infected epithelial cells is coupled to cell shape-responsive metabolic controls. J Cell Physiol (1983) 0.88
Cell-contact and -architecture of malignant cells and their relationship to metastasis. Cancer Metastasis Rev (1987) 0.87
Metaplasia, intraepithelial neoplasia and early cancer of the stomach are related to dedifferentiated epithelial cells defined by cytokeratin-7 expression in gastritis. Virchows Arch (2001) 0.87
Processing of SV40 RNA is associated with the nuclear matrix and is not followed by the accumulation of low-molecular-weight RNA products. Virology (1983) 0.86
Relationship between the organization and synthesis of vimentin and the metastatic capability of B16 melanoma cells. Cancer Res (1985) 0.85
Microsatellite instability in colorectal adenomas: relevance and clinical importance. Int J Colorectal Dis (2000) 0.85
DNA loops induced by cooperative binding of transcriptional activator proteins and preinitiation complexes. Proc Natl Acad Sci U S A (1995) 0.85
The migrating cancer stem cells model--a conceptual explanation of malignant tumour progression. Ernst Schering Found Symp Proc (2006) 0.82
Tumor patterning: analogies of neoplastic morphogenesis with embryogenesis. Verh Dtsch Ges Pathol (2000) 0.82
Contrasting effects of K8 and K18 on stabilizing K19 expression, cell motility and tumorigenicity in the BSp73 adenocarcinoma. J Cell Sci (1997) 0.82
The pattern of cytokeratin synthesis is a marker of type 2 cell differentiation in adult and maturing fetal lung alveolar cells. Dev Biol (1988) 0.82
Inhibition of vimentin synthesis and disruption of intermediate filaments in simian virus 40-infected monkey kidney cells. Mol Cell Biol (1984) 0.82
Association of glycoconjugates with the cytoskeletal framework. Mol Cell Biol (1983) 0.81
Cell-cell interaction and cell configuration related control of cytokeratins and vimentin expression in epithelial cells and in fibroblasts. Ann N Y Acad Sci (1985) 0.81
Structure-function relationships in the differentiating granulosa cell. Prog Clin Biol Res (1989) 0.80
Ki-67 expression and residual tumour (R) classification are associated with disease-free survival in desmoid tumour patients. Anticancer Res (2002) 0.80
Hodgkin's disease and peripheral T-cell lymphoma: composite lymphoma with evidence of Epstein-Barr virus infection. J Pathol (2000) 0.80
Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression. Oncogene (2015) 0.80
Interferon-gamma treatment of B16 melanoma cells: opposing effects for non-adaptive and adaptive immune defense and its reflection by metastatic spread. Int J Cancer (1988) 0.79
Cloning of a cDNA coding for the acetylcholine receptor alpha-subunit from a thymoma associated with myasthenia [correction of myastenia] gravis. Thymus (1994) 0.79
Apoptosis in chronic gastritis and its correlation with antigastric autoantibodies. Virchows Arch (1998) 0.79